van de Belt H, Neut D, Schenk W, van Horn J R, van der Mei H C, Busscher H J
Department of Orthopedic Surgery, University Hospital Groningen, The Netherlands.
Acta Orthop Scand. 2001 Dec;72(6):557-71. doi: 10.1080/000164701317268978.
Infections by bacteria are a serious complication following orthopedic implant surgery, that can usually only be cured by removing the implant, since the biofilm mode of growth of infecting bacteria on an implant surface protects the organisms from the host immune system and antibiotic therapy. Over the past few decades, attempts have been made to prevent and cure orthopedic implant infections by incorporating antibiotics in polymethylmethacrylate bone cements, in primary and revision surgery. However, the clinical efficacy of antibiotic-releasing bone cements is not accepted by all and the long-term exposure to low doses from antibiotic-releasing bone cements in patients is strongly related to the emerging threat of antibiotic resistance in medicine today. In this article, we start by reviewing the mechanisms governing the formation of an infectious biofilm on orthopedic implant materials, the release mechanisms and properties of clinically-used, antibiotic-loaded bone cements. The clinical efficacy of antibiotic-loaded bone cements is evaluated analyzing separatedly the prophylactic and therapeutic uses of these products.
细菌感染是骨科植入手术之后的一种严重并发症,通常只能通过移除植入物来治愈,因为感染细菌在植入物表面的生物膜生长模式可保护这些微生物免受宿主免疫系统和抗生素治疗的影响。在过去几十年里,人们尝试在初次手术和翻修手术中通过将抗生素掺入聚甲基丙烯酸甲酯骨水泥来预防和治疗骨科植入物感染。然而,抗生素释放骨水泥的临床疗效并未得到所有人的认可,而且患者长期接触来自抗生素释放骨水泥的低剂量抗生素与当今医学中抗生素耐药性这一新兴威胁密切相关。在本文中,我们首先回顾了骨科植入材料上感染性生物膜形成的控制机制、临床使用的载抗生素骨水泥的释放机制和特性。通过分别分析这些产品的预防性和治疗性用途来评估载抗生素骨水泥的临床疗效。